Business Description
Ypsomed Holding AG
ISIN : CH0019396990
Description
Ypsomed Holding AG is a Swiss company that develops and manufactures injection and infusion systems that allow patients to self-administer medication. Specifically, the company focuses on ensuring the ease of diabetes and insulin injection. The company offers various products such as pen needles with a unique click-on function. The company operates under two reportable segments: diabetes care and delivery systems goods and services. Diabetes care and delivery systems goods and services compose 55% and 40% of the company's sales, respectively.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.23 | |||||
| Equity-to-Asset | 0.61 | |||||
| Debt-to-Equity | 0.27 | |||||
| Debt-to-EBITDA | 0.99 | |||||
| Interest Coverage | 23.54 | |||||
| Piotroski F-Score | 7/9 | |||||
| Altman Z-Score | 10.77 | |||||
| Beneish M-Score | -2.77 | |||||
| WACC vs ROIC | ||||||
Growth Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 5.9 | |||||
| 3-Year EBITDA Growth Rate | 28.2 | |||||
| 3-Year EPS without NRI Growth Rate | 62.3 | |||||
| 3-Year FCF Growth Rate | 18.8 | |||||
| 3-Year Book Growth Rate | 11.3 | |||||
| Future 3-5Y Total Revenue Growth Rate | 15.07 |
Momentum Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 11.37 | |||||
| 9-Day RSI | 23.44 | |||||
| 14-Day RSI | 32.52 | |||||
| 6-1 Month Momentum % | 44.58 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 0.77 | |||||
| Quick Ratio | 0.56 | |||||
| Cash Ratio | 0.11 | |||||
| Days Inventory | 69.75 | |||||
| Days Sales Outstanding | 64.66 | |||||
| Days Payable | 22.85 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 0.38 | |||||
| Dividend Payout Ratio | 0.24 | |||||
| 3-Year Dividend Growth Rate | 3.1 | |||||
| Forward Dividend Yield % | 0.38 | |||||
| 5-Year Yield-on-Cost % | 0.17 | |||||
| 3-Year Average Share Buyback Ratio | -2.6 | |||||
| Shareholder Yield % | 2.76 |
Profitability Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 32.04 | |||||
| Operating Margin % | 15.93 | |||||
| Net Margin % | 14.24 | |||||
| FCF Margin % | -8.36 | |||||
| ROE % | 13.21 | |||||
| ROA % | 8.39 | |||||
| ROIC % | 8.45 | |||||
| ROC (Joel Greenblatt) % | 20.3 | |||||
| ROCE % | 14.05 | |||||
| Years of Profitability over Past 10-Year | 10 |
GF Value Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 63.32 | |||||
| PE Ratio without NRI | 63.32 | |||||
| Shiller PE Ratio | 129.06 | |||||
| Price-to-Owner-Earnings | 160.49 | |||||
| PEG Ratio | 23.45 | |||||
| PS Ratio | 9.05 | |||||
| PB Ratio | 8.03 | |||||
| Price-to-Tangible-Book | 14.54 | |||||
| Price-to-Operating-Cash-Flow | 34.54 | |||||
| EV-to-EBIT | 58.06 | |||||
| EV-to-Forward-EBIT | 31.62 | |||||
| EV-to-EBITDA | 29.86 | |||||
| EV-to-Forward-EBITDA | 17.67 | |||||
| EV-to-Revenue | 9.32 | |||||
| EV-to-Forward-Revenue | 6.53 | |||||
| EV-to-FCF | -111.4 | |||||
| Price-to-Projected-FCF | 35.82 | |||||
| Price-to-Median-PS-Value | 2.08 | |||||
| Price-to-Graham-Number | 6.4 | |||||
| Earnings Yield (Greenblatt) % | 1.72 | |||||
| FCF Yield % | -0.92 | |||||
| Forward Rate of Return (Yacktman) % | 1.61 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Ypsomed Holding AG Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil CHF) | 508.606 | ||
| EPS (TTM) (CHF) | 5.33 | ||
| Beta | 0.37 | ||
| Volatility % | 102.19 | ||
| 14-Day RSI | 32.52 | ||
| 14-Day ATR (CHF) | 11.215523 | ||
| 20-Day SMA (CHF) | 368.4 | ||
| 12-1 Month Momentum % | 0 | ||
| 52-Week Range (CHF) | 243.5 - 389.5 | ||
| Shares Outstanding (Mil) | 13.65 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 7 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Ypsomed Holding AG Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Ypsomed Holding AG Stock Events
| Event | Date | Price(CHF) | ||
|---|---|---|---|---|
| No Event Data | ||||
Ypsomed Holding AG Frequently Asked Questions
What is Ypsomed Holding AG(CHIX:YPSNz)'s stock price today?
The current price of CHIX:YPSNz is CHF338.50. The 52 week high of CHIX:YPSNz is CHF389.50 and 52 week low is CHF243.50.
When is next earnings date of Ypsomed Holding AG(CHIX:YPSNz)?
The next earnings date of Ypsomed Holding AG(CHIX:YPSNz) is .
Does Ypsomed Holding AG(CHIX:YPSNz) pay dividends? If so, how much?
The Dividend Yield %  of Ypsomed Holding AG(CHIX:YPSNz) is 0.38% (As of Today), Highest Dividend Payout Ratio of Ypsomed Holding AG(CHIX:YPSNz) was 0.86. The lowest was 0.16. And the median was 0.29. The  Forward Dividend Yield % of Ypsomed Holding AG(CHIX:YPSNz) is 0.38%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers